TransMedics Stocks Drop 58% Despite First Profitability After 26 Years
TransMedics (TMDX), a Nasdaq-listed organ transport technology company founded in 1998 by cardiac surgeon Dr. Walid Hassanein, experienced a significant stock decline in 2025 despite achieving first-time profitability in 2024 after 26 years of operation. The company's stock dropped from $177 in
LucasBennett·08-02 06:03
